Cataract Clinical Trial
Official title:
A Prospective Multicenter Study to Assess The Clinical Outcomes of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery
Verified date | January 2024 |
Source | Carl Zeiss Meditec, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research study is to evaluate the clinical outcomes of the use of low-energy segment removal with a micro-interventional irrigation/aspiration port (MICOR-304) to evacuate the lens prior to intraocular lens insertion in subjects undergoing routine cataract surgery.
Status | Enrolling by invitation |
Enrollment | 300 |
Est. completion date | December 2025 |
Est. primary completion date | November 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Able to understand study requirements, willing to follow study instructions and willing to return for required study follow-up visits 2. Willing and able to understand and complete the informed consent document 3. Subjects with a cataract grade of 1 to 3+ and are scheduled to undergo cataract surgery 4. Subjects = 18 years of age 5. Clear intraocular media, other than cataract Exclusion Criteria: 1. Polar cataracts 2. Zonular instability 3. History of dry eye treatments/devices and or dry eye medications other than artificial tears. 4. Concurrent participation or participation in any clinical trial up to 30 days prior to preoperative visit 5. Subjects that are pregnant, lactating or planning to become pregnant during the course of the study |
Country | Name | City | State |
---|---|---|---|
United States | Chu Vision Institute | Bloomington | Minnesota |
United States | Argus Research at Cape Coral Eye Center | Cape Coral | Florida |
United States | Young H. Choi Eye Surgery Center | Vestavia Hills | Alabama |
Lead Sponsor | Collaborator |
---|---|
Carl Zeiss Meditec, Inc. | Carl Zeiss Meditec Cataract Technology, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Total lens removal time | Total lens removal time is defined in two phases: The beginning time starts when the surgeon enters the eye with the MICOR-304 to start the lens removal process and completing when the surgeon finishes the nucleus lens removal with the MICOR-304 before changing over to irrigation and aspiration. o The second phase of lens removal time is the irrigation and aspiration stage for cortex removal which starts when the irrigation and aspiration tip enters the eye and completion time is when the cortex is removed. The total lens removal time as defined above is recorded in minutes and seconds. |
Assessed during the surgical procedure. | |
Primary | Amount of irrigation solution fluid volume used during the surgical procedure | Total irrigation solution volume will be recorded using the indicators on the bag which will have labels that have pre-defined markers to indicate milliliters (ml) of volume of irrigation solution used for the surgical procedure. | Assessed during the surgical procedure. | |
Secondary | Uncorrected Visual Acuity | Assessment of Uncorrected Visual Acuity. | Postoperative days 1, 7, and 30. | |
Secondary | Change in corneal thickness | Assessment in change in corneal thickness from baseline through end of study. | Baseline through 30 days postoperative. | |
Secondary | Rate of occurrence of intraoperative and postoperative adverse events | Assessment of intraoperative and postoperative adverse events. | From study enrollment through study completion at 1 month postoperative. | |
Secondary | Corneal Edema | Corneal edema will be assessed as the following: 0=None, 1+=Mild, 2+=Moderate and 3+=Severe assessed via slit-lamp. | Pre-operative, 1-day, 1-week and 1-month postoperative study completion. | |
Secondary | Corneal Cells | Corneal cells will be assessed as the following: 0=>1 cell, 0.5+=1-5 cells, 1+=6-15 cells, 2+=16-25 cells, 3+=26-50 cells and 4+=>50 cells assessed via slit-lamp. | Pre-operative, 1-day, 1-week and 1-month postoperative study completion. | |
Secondary | Anterior Chamber Flare | Anterior chamber flare will be assessed as the following: 0-None, 1+=Faint, 2+=Moderate, (iris and lens details clear), 3+=Marked (iris and lens details hazy), 4+=Intense fibrin or plastic aqueous assessed via slit-lamp. | Pre-operative, 1-day, 1-week and 1-month postoperative study completion. | |
Secondary | Posterior Capsule Opacification | Posterior capsule opacification will be assessed as the following: none, minimal, mild, moderate and severe assessed via slit-lamp. | Pre-operative, 1-day, 1-week and 1-month postoperative study completion. | |
Secondary | Corneal Staining Erosion | Corneal staining erosion will be assessed as the following: 0=None, 1+=Mild, 2+=Moderate and 3=Severe assessed via slit-lamp. | Pre-operative, 1-day, 1-week and 1-month postoperative study completion. | |
Secondary | Disc Appearance | Disc appearance is assessed as normal and abnormal with free text to specify if abnormal, assessed via dilated fundus examination. | Pre-operative and 1-month postoperative study completion. | |
Secondary | Macula | Macula is assessed as normal and abnormal with free text to specify if abnormal, assessed via dilated fundus examination. | Pre-operative and 1-month postoperative study completion. | |
Secondary | Vessels | Vessels are assessed as normal and abnormal with free text to specify if abnormal, assessed via dilated fundus examination. | Pre-operative and 1-month postoperative study completion. | |
Secondary | Periphery | Periphery is assessed as normal and abnormal with free text to specify if abnormal, assessed via dilated fundus examination. | Pre-operative and 1-month postoperative study completion. | |
Secondary | Total Surgical Procedure Time | Total Surgical Procedure Time time is defined as the beginning time when the surgeon makes the first incision in the eye and completion time is when the eye speculum is removed at the end of the procedure. Total surgical procedure time is recorded in minutes and seconds. | Assessed during the surgical procedure. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |